Standout Papers

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marro... 1997 2026 2006 2016 985
  1. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. (1997)
    Robert H. Collins, Ofer Shpilberg et al. Journal of Clinical Oncology
  2. Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy (1997)
    Sergio Giralt, Elihu H. Estey et al. Blood
  3. Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia (2004)
    Mary J. Laughlin, Mary Eapen et al. New England Journal of Medicine
  4. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. (2002)
    Matus Studeny, Frank C. Marini et al. PubMed
  5. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. (1998)
    Issa F. Khouri, Michael J. Keating et al. Journal of Clinical Oncology
  6. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. (1988)
    Ernest S. Kawasaki, SS Clark et al. Proceedings of the National Academy of Sciences
  7. Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells (2002)
    Martin Körbling, Ruth L. Katz et al. New England Journal of Medicine
  8. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study (2007)
    Mary Eapen, Pablo Rubinstein et al. The Lancet
  9. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia (2000)
    Jeffrey J. Molldrem, Peter P. Lee et al. Nature Medicine
  10. Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells (2012)
    Cecele J. Denman, V. V. Senyukov et al. PLoS ONE

Immediate Impact

3 by Nobel laureates 24 from Science/Nature 98 standout
Sub-graph 1 of 19

Citing Papers

Natural killer cell therapies
2024 StandoutNature
Co-opting signalling molecules enables logic-gated control of CAR T cells
2023 StandoutNature
15 intermediate papers

Works of Richard E. Champlin being referenced

Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity
2015
Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials
2013
and 6 more

Author Peers

Author Last Decade Papers Cites
Richard E. Champlin 26783 14687 12379 1.1k 44.5k
Arnon Nagler 21125 12317 12354 1.1k 38.4k
Rainer Storb 48293 15562 18987 1.1k 66.3k
Daniel J. Weisdorf 23840 11247 13130 725 37.6k
Stephen J. Forman 12044 15823 8877 850 35.1k
Sergio Giralt 21065 9804 6925 848 29.6k
Frederick R. Appelbaum 30424 9902 6874 594 41.8k
Franco Locatelli 12147 8243 9706 998 32.1k
H. Joachim Deeg 22839 7066 6713 666 30.5k
Gèrard Socié 18299 7253 8911 692 29.4k
Paul J. Martin 20140 6825 12312 562 33.6k

All Works

Loading papers...

Rankless by CCL
2026